A mixture of 7-methoxy-1-methyl-9H-pyrido [3,4-b]indole (1.02 g, 5 mmol) and NaH (240 mg, 10 mmol) were dissolved in DMF (30 mL). Then bromoethane (0.43 mL, 6 mmol) was added dropwise. After stirred for 4 hour at room temperature, the mixture were poured into water and extracted with ethyl acetate. The organic phase was washed with water and brine respectively, and dried over Na 2 SO 4 . After removing the solvent, the crude product was purified by column chromatography on silica gel, affording the title compound (yield: 1.05 g, 87.5%). The compound was then dissolved in acetone/H 2 O, and colourless crystals were formed on slow evaporation at room temperature over one week.
Discussion
Carboline (9H-pyrido [3,4-b] indole) derivatives have been widely explored as anticancerous and antimicrobial drugs [1, 2] . As a result of our program of screening new anticancerous activity constituents, as an intermediate the title compound has been obtained. In the title molecule, the carboline system lies approximately in a plane and the maximum displacement from the leastsquare plane defined by all the 13 atoms of the carboline framework is 0.028(3) Å for C10 atom. The ethyl group is out of the plane, and the distance between C13 atom of ethyl group and the carboline plane is 1.145(4) Å. The title structure crystallizes in the tetragonal space group I4 1 a which is different from that of its precursor harmine (7-methoxy-1-methyl-9H-pyrido [3,4- (2 
